+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines



Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines



Arzneimittel-Forschung 31(3): 524-526



2-Hydroxy-(1-hydroxy-[(1-methyl-3-phenylpropyl)amino]-2-ethyl)-5-benzamide (labetalol), a new alpha- and beta-adrenergic blocking agent, was employed in 21 patients with severe hypertension by slow (6 patients) and rapid (15 patients) i.v. infusion. A marked and significant fall of blood pressure was observed in both groups, though more gradual in patients treated by slow infusion. A rapid blood pressure fall with cardiac output decrease was observed by passing from supine to standing position in the first hours after infusion. Therefore, it is advisable to keep a supine position for a few hours. Plasma renin activity decreased after labetalol infusion, but basal plasma renin levels were not related to hypotensive effect of labetalol. In slow infusion patients, plasma noradrenaline levels increased and no changes of plasma adrenaline levels were observed during infusion. The most likely explanation of these variations is an increase of sympathetic activity secondary to hypotension, caused by labetalol, whereas a technical interference seems to be excluded. The simultaneous blockade of alpha- and beta-receptors can inhibit, in this case, the pressor effects of the sympathetic reflex.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043458748

Download citation: RISBibTeXText

PMID: 7013770


Related references

Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight. Acta Medica Scandinavica. Supplementum 625: 59-64, 1979

Effects of nifedipine on blood pressure, regional hemodynamics, plasma renin activity and plasma catecholamines in patients with arterial hypertension. Acta Medica Scandinavica. Supplementum 625: 65-67, 1979

Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension. European Journal of Clinical Pharmacology 16(5): 305-310, 1979

Effect of pinacidil on blood pressure plasma catecholamines and plasma renin activity in essential hypertension. European Journal of Clinical Pharmacology 28(5): 495-500, 1985

Blood catecholamines, plasma renin activity and arterial blood pressure in patients with hypertension. Polskie Archiwum Medycyny Wewnetrznej 58(5): 501-508, 1977

Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise. European Journal of Clinical Pharmacology 9(1): 9-19, 1975

Interrelations among blood pressure blood volume plasma renin activity and urinary catecholamines in benign essential hypertension. American Journal of Medicine 62(2): 209-218, 1977

Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension. Clinical Pharmacology and Therapeutics 31(4): 445-451, 1982

Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity. Japanese Circulation Journal 36(12): 1301-1311, 1972

Effects of caffeine on plasma renin activity, catecholamines and blood pressure. New England Journal of Medicine 298(4): 181-186, 1978

Effect of intravenous iv dilevalol d on blood pressure bp plasma renin activity pra and plasma epinephrine e and norepinephrine ne levels in severe hypertensives. Clinical Research 35(3): 440A, 1987

Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension. British Journal of Clinical Pharmacology 10 Suppl 1: 109s-114s, 1980

Effects of low-dose atenolol on postural and postprandial changes in heart rate, blood pressure, venous plasma catecholamines, and plasma renin activity. European Journal of Clinical Pharmacology 37(2): 121-125, 1989

Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. European Journal of Clinical Pharmacology 22(6): 491-493, 1982

The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure heart rate working capacity plasma renin activity plasma angiotensin ii urinary catecholamines and aldosterone in patients with essential hypertension. British Journal of Clinical Pharmacology 21(6): 633-640, 1986